Charles N. Pegram
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology top 10%
- Oncology top 5%
- Genetics top 1%
- Immunology top 5%
- Co-authors
- Darell D. BignerCarol J. WikstrandRoger E. McLendonMichael R. ZalutskyHenry S. FriedmanCraig J. ReistR. Edward ColemanSurinder K. Batra
- Topics
- Radiopharmaceutical Chemistry and Applications (18 papers)Monoclonal and Polyclonal Antibodies Research (13 papers)Glioma Diagnosis and Treatment (12 papers)
- Partner nations
- United StatesSwedenChina
In The Last Decade
Charles N. Pegram
46 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 82
- Radiology, Nuclear Medicine and Imaging 904
- Molecular Biology 855
- Oncology 830
- Genetics 611
- Immunology 521
Countries citing papers authored by Charles N. Pegram
This map shows the geographic impact of Charles N. Pegram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles N. Pegram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles N. Pegram more than expected).
Fields of papers citing papers by Charles N. Pegram
This network shows the impact of papers produced by Charles N. Pegram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles N. Pegram. The network helps show where Charles N. Pegram may publish in the future.
Co-authorship network of co-authors of Charles N. Pegram
This figure shows the co-authorship network connecting the top 25 collaborators of Charles N. Pegram. A scholar is included among the top collaborators of Charles N. Pegram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles N. Pegram. Charles N. Pegram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 6 | |
| 3 | 58 | |
| 4 | 8 | |
| 5 | 26 | |
| 6 | 18 | |
| 7 | 42 | |
| 8 | 85 | |
| 9 | 10 | |
| 10 | 14 | |
| 11 | 32 | |
| 12 | 11 | |
| 13 | 52 | |
| 14 | 154 | |
| 15 | 35 | |
| 16 | 7 | |
| 17 | 96 | |
| 18 | Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. | 385 |
| 19 | 14 | |
| 20 | 24 |
About Charles N. Pegram
Charles N. Pegram is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (18 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Glioma Diagnosis and Treatment (12 papers). The work is most often cited by research in Genetics (611 citations), Radiology, Nuclear Medicine and Imaging (904 citations) and Oncology (830 citations). Charles N. Pegram has collaborated with scholars based in United States, Sweden and China. Frequent co-authors include Darell D. Bigner, Carol J. Wikstrand, Roger E. McLendon, Michael R. Zalutsky, Henry S. Friedman, Craig J. Reist, R. Edward Coleman, Surinder K. Batra, James E. Herndon and Allan H. Friedman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.